CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus

Ching Chen1,2, Liang-Yu Lin2,3, Jaw-Wen Chen1,2,4,5,6,7

  • 1Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan.

PubMed
Abstract

Insights

Higher chemokine C-X-C motif ligand 5 (CXCL5) levels are linked to type 2 diabetes. Suppressing CXCL5 improves blood vessel formation and wound healing in diabetic models by targeting CXCR2.

Area of Science:

  • Endocrinology and Metabolism
  • Vascular Biology
  • Immunology

Background:

  • Elevated chemokine C-X-C motif ligand 5 (CXCL5) levels are observed in type 2 diabetes mellitus (DM) patients.
  • The specific role of CXCL5 in diabetic vasculopathy, particularly in neovascularization and wound healing, remains unclear.

Purpose of the Study:

  • To investigate the impact of CXCL5 on neovascularization and wound healing in diabetes mellitus.
  • To elucidate the underlying mechanisms by which CXCL5 influences these processes in diabetic conditions.

Main Methods:

  • In vitro studies utilized endothelial progenitor cells (EPCs) and human aortic endothelial cells (HAECs).
  • In vivo studies employed streptozotocin-induced diabetic mice, Leprdb/JNarl mice, and CXCL5 knockout diabetic mice.
  • Functional assessments included hindlimb ischemia, aortic ring assays, matrigel plug assays, and wound healing assays.

Main Results:

  • CXCL5 levels were increased in plasma and EPCs from type 2 DM patients.
  • CXCL5 neutralization upregulated VEGF/SDF-1, enhancing cell function and promoting neovascularization and wound healing in diabetic models.
  • CXCL5 promoted inflammation (IL-1β, IL-6, TNF-α) and suppressed VEGF/SDF-1 via ERK/p65 activation through CXCR2.

Conclusions:

  • Suppression of CXCL5 enhances neovascularization and wound healing in diabetes by acting through the CXCR2 pathway.
  • CXCL5 represents a potential therapeutic target for managing vascular complications associated with diabetes mellitus.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
49
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K